Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager

Swedish Orphan Biovitrum AB (publ)

STO:SOBI

Watchlist

Dividends

Price: 290 SEK -0.21% Market Closed

Market Cap: 99.8B SEK

Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 290 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SOBI Alert

Swedish Orphan Biovitrum AB (publ)

290

-0.6 (-0.21%)

52 Week Range	239.4 346.4
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Swedish Orphan Biovitrum AB (publ)

What unique competitive advantages
does Swedish Orphan Biovitrum AB (publ) hold over its rivals?

What risks and challenges
does Swedish Orphan Biovitrum AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Swedish Orphan Biovitrum AB (publ).

What unique competitive advantages
does Swedish Orphan Biovitrum AB (publ) hold over its rivals?

What risks and challenges
does Swedish Orphan Biovitrum AB (publ) face in the near future?

Has there been any significant insider trading activity
in Swedish Orphan Biovitrum AB (publ) recently?

Summarize the latest earnings call
of Swedish Orphan Biovitrum AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Swedish Orphan Biovitrum AB (publ).

Provide P/S
for Swedish Orphan Biovitrum AB (publ).

Provide P/E
for Swedish Orphan Biovitrum AB (publ).

Provide P/OCF
for Swedish Orphan Biovitrum AB (publ).

Provide P/FCFE
for Swedish Orphan Biovitrum AB (publ).

Provide P/B
for Swedish Orphan Biovitrum AB (publ).

Provide EV/S
for Swedish Orphan Biovitrum AB (publ).

Provide EV/GP
for Swedish Orphan Biovitrum AB (publ).

Provide EV/EBITDA
for Swedish Orphan Biovitrum AB (publ).

Provide EV/EBIT
for Swedish Orphan Biovitrum AB (publ).

Provide EV/OCF
for Swedish Orphan Biovitrum AB (publ).

Provide EV/FCFF
for Swedish Orphan Biovitrum AB (publ).

Provide EV/IC
for Swedish Orphan Biovitrum AB (publ).

Show me price targets
for Swedish Orphan Biovitrum AB (publ) made by professional analysts.

What are the Revenue projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past Revenue estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the Net Income projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past Net Income estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the EPS projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past EPS estimates
for Swedish Orphan Biovitrum AB (publ)?

What are the EBIT projections
for Swedish Orphan Biovitrum AB (publ)?

How accurate were the past EBIT estimates
for Swedish Orphan Biovitrum AB (publ)?

Compare the revenue forecasts
for Swedish Orphan Biovitrum AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Swedish Orphan Biovitrum AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Swedish Orphan Biovitrum AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Swedish Orphan Biovitrum AB (publ) compared to its peers.

Compare the P/E ratios
of Swedish Orphan Biovitrum AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Swedish Orphan Biovitrum AB (publ) with its peers.

Analyze the financial leverage
of Swedish Orphan Biovitrum AB (publ) compared to its main competitors.

Show all profitability ratios
for Swedish Orphan Biovitrum AB (publ).

Provide ROE
for Swedish Orphan Biovitrum AB (publ).

Provide ROA
for Swedish Orphan Biovitrum AB (publ).

Provide ROIC
for Swedish Orphan Biovitrum AB (publ).

Provide ROCE
for Swedish Orphan Biovitrum AB (publ).

Provide Gross Margin
for Swedish Orphan Biovitrum AB (publ).

Provide Operating Margin
for Swedish Orphan Biovitrum AB (publ).

Provide Net Margin
for Swedish Orphan Biovitrum AB (publ).

Provide FCF Margin
for Swedish Orphan Biovitrum AB (publ).

Show all solvency ratios
for Swedish Orphan Biovitrum AB (publ).

Provide D/E Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide D/A Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Interest Coverage Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Altman Z-Score Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Quick Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Current Ratio
for Swedish Orphan Biovitrum AB (publ).

Provide Cash Ratio
for Swedish Orphan Biovitrum AB (publ).

What is the historical Revenue growth
over the last 5 years for Swedish Orphan Biovitrum AB (publ)?

What is the historical Net Income growth
over the last 5 years for Swedish Orphan Biovitrum AB (publ)?

What is the current Free Cash Flow
of Swedish Orphan Biovitrum AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Swedish Orphan Biovitrum AB (publ).

EV/EBITDA
Enterprise Value to EBITDA

11.5

Current

12.1

Median

4.2

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

11.5

Enterprise Value

110.7B SEK

EBITDA

9.7B SEK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
SE		Swedish Orphan Biovitrum AB (publ) STO:SOBI	99.6B SEK	11.5
FR		Pharnext SCA OTC:PNEXF	6T USD	-219 796.6
US		Abbvie Inc NYSE:ABBV	312.7B USD	15.3
US		Amgen Inc NASDAQ:AMGN	158.3B USD	17.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	24.1
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	9.9
US	E	Epizyme Inc F:EPE	94.1B EUR	-514.1
AU		CSL Ltd ASX:CSL	133.6B AUD	20.3
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	15.9
US	S	Seagen Inc F:SGT	39.3B EUR	-58.7
NL		argenx SE XBRU:ARGX	34.8B EUR	-105.5

				EBITDA Growth
SE		Swedish Orphan Biovitrum AB (publ) STO:SOBI	Average EV/EBITDA: 16.3 11.5	72%
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -219 796.6	N/A
US		Abbvie Inc NYSE:ABBV	15.3	29%
US		Amgen Inc NASDAQ:AMGN	17.5	62%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	24.1	43%
US		Gilead Sciences Inc NASDAQ:GILD	9.9	16%
US	E	Epizyme Inc F:EPE	Negative Multiple: -514.1	N/A
AU		CSL Ltd ASX:CSL	20.3	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	15.9	35%
US	S	Seagen Inc F:SGT	Negative Multiple: -58.7	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -105.5	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

11.7

2-Years Forward

EV/EBITDA

9.9

3-Years Forward

EV/EBITDA

8.2

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Swedish Orphan Biovitrum AB (publ) STO:SOBI

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

EV/EBITDA
Enterprise Value to EBITDA